Intellectual Property India Publishes Patent Application for 'Human Complement Component 2 Binding Molecules' Filed by The Cleveland Clinic Foundation

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517096224 A) filed by The Cleveland Clinic Foundation, Cleveland, U.S.A., on Oct. 7, for 'human complement component 2 binding molecules.'

Inventor(s) include Lin, Feng.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are human complement component 2 (C2) binding molecules and nucleic acid sequences encoding such molecules. In particular embodiments, provided herein are human C2 binding molecules (e.g., nanobodies) having a first, and optionally a second, single monomeric variable antibody domain (SMVAD) that comprises certain...